Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Brain scans and imaging

Topic: Risk, prevention and care in population studies

Cognitively normal older adults are often regarded as a homogeneous population in preventive and disease-modifying clinical trials for dementia. However, longer-term cognitive aging outcomes vary substantially in this population, and this variability remains poorly understood. Here, we leveraged rich multimodal, multi-domain biomarker profiles from a large prospective cohort (N=1,136), and Deep Embedded Clustering, to cluster cognitively normal older adults into biologically distinct subgroups. Input data included cortical thickness derived from MRI, plasma Alzheimers disease (AD) biomarkers, plasma inflammatory biomarkers, and vascular measures. The deep clustering algorithm identified three biologically distinct subgroups within the sample, stratified along a gradient of neurobiological burden (low, intermediate, and high). Cortical thinning and inflammatory burden were the primary drivers of clustering assignments. The High-Burden subgroup showed significantly worse memory and executive function, elevated cardiometabolic comorbidity, and markedly higher rates of conversion to mild cognitive impairment or dementia within two years. The results were validated in an independent external sample. The study reveals marked variability among individuals who are otherwise all defined as cognitively normal, and provides a data-driven stratification framework for enriching disease-modifying and preventive trials by identifying cognitively normal individuals at high risk for future cognitive decline.

Key findings

Why it matters

Among cognitively normal older adults, a high-burden subgroup identified by clustering had worse memory and executive function and much higher rates of conversion to mild cognitive impairment or dementia within two years. The authors present this as a data-driven way to stratify people for prevention trials.

Study details

How this study scored 16/100
How this study's score is builtJournal tier 2 of 10; Journal's citation record 0 of 4; Study design 7 of 12; Strength of evidence 3 of 5; Peer-review validation 4 of 10; How recent 5 of 5; Sample size 3 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year left out, no data; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 0 of 4; Institution's track record 2 of 3; Multi-centre collaboration 0 of 3; Indexed in PubMed 1 of 2; Free to read 2 of 2. 32 of the 94 points it could be judged on, which is 34 of 100. Raw total 34 of 100, shown as 16 because this is not a peer-reviewed research article.raw total 34 of 100capped at 16 — hatched points do not count

Preprint — not yet peer-reviewed. It scored 34 on the same rubric, but non-peer-reviewed sources are capped at 16, so it shows as 16. Scored zero for effect reported and randomised / blinded because the record does not state it. We have no data on impact for its field and year, so that was left out: it earned 32 of the 94 points we could judge it on, which is 34 out of 100.

ComponentPointsWhy
Journal tier 2 / 10 Tier 4 — not a peer-reviewed journal (medRxiv (preprint))
Journal's citation record 0 / 4 Not a journal article, so the journal's record does not count
Study design 7 / 12 A prospective cohort study, followed forward from enrollment
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 4 / 10 Preprint — not yet peer-reviewed. Hosted on a preprint server.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 3 / 4 1,136 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 2 year(s) since 2026
Impact for its field and year — / 6 No field-weighted citation impact (OpenAlex has none yet) — left out of this score
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 0 / 4 Last-listed author the Frontotemporal Lobar Degeneration Neuroimaging Initiative: h-index 4 (OpenAlex, whole career)
Institution's track record 2 / 3 University of North Carolina at Chapel Hill: institution h-index 1,674 (OpenAlex)
Multi-centre collaboration 0 / 3 OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 2 / 2 Free to read
Points 32 / 94 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 32 of the 94 points we could judge it on is 34 out of 100.
Total 34 / 100 Capped to 16 because this is not a peer-reviewed article.

What each of these 20 components measures, and what this score is not →

Read the original

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Diaz, M. M., & Dayan, E. (2026). Deep multimodal clustering identifies biological subtypes of normal aging with divergent cognitive decline risk. medRxiv (preprint). https://doi.org/10.64898/2026.08.18.26360683

Vancouver

Diaz MM, Dayan E. Deep multimodal clustering identifies biological subtypes of normal aging with divergent cognitive decline risk. medRxiv (preprint). 2026. doi:10.64898/2026.08.18.26360683.

BibTeX

@article{diaz2026-a064c939,
  author  = {Diaz, M. M. and Dayan, E.},
  title   = {{Deep multimodal clustering identifies biological subtypes of normal aging with divergent cognitive decline risk}},
  journal = {medRxiv (preprint)},
  year    = {2026},
  doi     = {10.64898/2026.08.18.26360683},
  url     = {https://doi.org/10.64898/2026.08.18.26360683}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 17.

Related studies in Brain scans and imaging

Also tagged “biobank”

1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.

Similar studies

More on Brain scans and imaging

See all studies in Brain scans and imaging →